OnCo

FOXO1 (Forkhead box protein O1) is a protein that switches other genes on and off. The public catalogues list it as an oncogene driver, a tumour suppressor, a biomarker and a fusion partner, and clinical evidence ties its variants to diagnosis, prognosis or drug response. Tied to Sarcomas, Non-Hodgkin lymphoma, Ovarian cancer and 4 more. This dossier gathers the 0 products (0 approved), 0 trials, 0 pathways and 0 resistance routes in the corpus that involve it, with external identifiers so it can be joined to UniProt, ChEMBL, Open Targets and the rest of biology.

Biology

Transcription factor that is the main target of insulin signalling and regulates metabolic homeostasis in response to oxidative stress. Binds to the insulin response element (IRE) with consensus sequence 5'-TT[G/A]TTTTG-3' and the related Daf-16 family binding element (DBE) with consensus sequence 5'-TT[G/A]TTTAC-3'. Activity suppressed by insulin. Main regulator of redox balance and osteoblast numbers and controls bone mass. Orchestrates the endocrine function of the skeleton in regulating glucose metabolism. Also acts as a key regulator of chondrogenic commitment of skeletal progenitor cells in response to lipid availability: when lipids levels are low, translocates to the nucleus and promotes expression of SOX9, which induces chondrogenic commitment and suppresses fatty acid oxidation. Location: Cytoplasm; Nucleus (UniProt). Locus 13q14.11 (HGNC).

Where it is found
  • Sarcomas: Open Targets association 0.65 with sarcoma (MONDO_0005089)
  • Non-Hodgkin lymphoma: Open Targets association 0.58 with non-Hodgkin lymphoma (MONDO_0018908); IntOGen driver in 3 cohorts (MLYM, NHL)
  • Ovarian cancer: Open Targets association 0.50 with ovarian cancer (MONDO_0008170)
  • Rhabdomyosarcoma: Open Targets association 0.62 with rhabdomyosarcoma (MONDO_0005212)
  • Diffuse large B-cell lymphoma: CIViC evidence names this disease
  • Burkitt lymphoma: CIViC evidence names this disease; IntOGen driver in 2 cohorts (BL)
Class: transcription · Gene: FOXO1 · Facts checked 2026-09-23 · Target page

External identifiers

Built from HGNC, Ensembl, UniProt and ChEMBL ids

Products by modality and phase

Browse products →

No product in the corpus is aimed at this target yet.

No trial in the corpus names this target or one of its products.

Resistance routes

Unaddressed routes →

The resistance atlas has no route that names this target.

No pathway diagram carries this target as a node.

Companion diagnostics

Assay registry →

No companion diagnostic in the registry measures this target.

Preclinical models

All models →

No model entry for this target yet; check the cancer entries on the models page.

No open questions recorded for this target yet. Suggest one.

Literature

Preprints →
Latest papers · live from Europe PMC
Open in Europe PMC

Query for this target: (TITLE:"FOXO1" OR ABSTRACT:"FOXO1" OR TITLE:"forkhead box O1" OR ABSTRACT:"forkhead box O1" OR TITLE:"Forkhead box protein O1" OR ABSTRACT:"Forkhead box protein O1" OR TITLE:"FKH1" OR ABSTRACT:"FKH1" OR TITLE:"FOXO1A" OR ABSTRACT:"FOXO1A") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about FOXO1, not a curated reading list.

Export

The dossier as machine-readable JSON: identifiers from HGNC, Ensembl, UniProt and ChEMBL, products with status, trials, pathways, hotspots, open questions and assays. The full entity record is in the open API at /api/v1/entities/foxo1.json. Licence CC BY-NC 4.0.